ArticleActa Cardiologica Sinica2025
The Prognostic Role of Residual SYNTAX Score in Older Patients with Acute Coronary Syndrome.
Article in Acta Cardiologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dual Antiplatelet Therapy Duration May Affect the Clinical Outcomes in Older Patients with Acute Coronary Syndrome.Acta Cardiologica Sinica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Approximately half of the patients presenting with acute coronary syndrome have multivessel disease. There has been conflicting data regarding the residual coronary artery disease (CAD) burden and its impact on mortality, especially in older people. Therefore, we aimed to assess all-cause mortality and residual CAD burden in older patients with acute coronary syndrome. Methods: Patients over 75 years of age who presented with acute coronary syndrome and underwent percutaneous coronary intervention were retrospectively included in the study. After the index procedure, residual The Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) scores were calculated and the patients were divided into two groups as residual SYNTAX > 8 and < 8. In-hospital and long-term all-cause mortality were defined as the endpoints of the study. Results: Overall, 352 patients were included in the study. The mean age was 82.0 ± 4.8 years and 188 (53.4%) patients were female. The median follow-up was 35 (3-57) months. Both in-hospital and long-term mortality were significantly higher in the patients with residual SYNTAX sore > 8 (33.9% vs. 12.0% and 70.1% vs. 48.4% both p < 0.01, respectively). Kaplan-Meier analysis survival curves continued to separate showing increased mortality in the patients with residual SYNTAX score > 8 (p < 0.01). In multivariate Cox regression analysis, high residual CAD burden [residual Syntax score > 8, hazard ratio: 1.83 (1.30-2.56 95% confidence interval), p < 0.01], age, diabetes mellitus, left ventricular ejection fraction and renal insufficiency were associated with long-term all-cause mortality. Conclusions: Elderly patients with residual SYNTAX score > 8 had higher in-hospital and long-term all-cause mortality rates. Strategies aiming to reduce residual CAD burden by revascularization seem reasonable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.